Richard G Corrao

Title: The Innovative Journey of Richard G. Corrao: Pioneering Pediatric Formulations

Introduction

Richard G. Corrao, an accomplished inventor based in Jackson, NJ, has made significant contributions to the field of pharmaceuticals. With a focus on pediatric formulations, his work ensures that young patients can benefit from effective treatments. His sole patent has paved the way for advancements in making medications more palatable for children.

Latest Patents

Richard G. Corrao holds a patent for a pediatric formulation of gatifloxacin, a quinolone antibacterial agent. This innovative formulation effectively masks the bitter taste of gatifloxacin, allowing it to be used in pediatric applications. The patent details a crystalline co-precipitate of gatifloxacin combined with stearic acid and/or palmitic acid that successfully addresses the challenge of taste compliance in young patients. Notably, this formulation provides a full dosage cycle of approximately fourteen days while ensuring that gatifloxacin remains available for absorption from the stomach.

Career Highlights

Throughout his career, Richard has worked at Bristol-Myers Squibb Company, a prominent player in the pharmaceutical industry. His role has involved pioneering research and development activities aimed at improving drug formulations for pediatric patients. Richard's contributions have had a lasting impact on how medications are presented to children, ensuring their effectiveness and adherence to treatment plans.

Collaborations

Richard G. Corrao has collaborated with notable professionals in his field, including Krishnaswamy Srinivas Raghavan and Sunanda A. Ranadive. These collaborations have facilitated the exchange of ideas and knowledge, further enhancing the innovative processes involved in the development of effective pediatric formulations.

Conclusion

In summary, Richard G. Corrao represents a remarkable figure in the realm of pharmaceutical innovations. With his dedication to creating effective and palatable pediatric formulations, he has significantly contributed to improving the treatment experience for young patients. His work exemplifies the vital intersection of innovation and healthcare, inspiring future advancements in the field.